Vanda Pharmaceuticals Inc.
MULTIPLE MYELOMA TREATMENT
Last updated:
Abstract:
The invention relates generally to the treatment of multiple myeloma. One embodiment of the invention provides a method of treating multiple myeloma (MM) in an individual, the method comprising: administering to the individual an effective amount of trichostatin A (TSA).
Status:
Application
Type:
Utility
Filling date:
26 Aug 2019
Issue date:
9 Jan 2020